Keep Watch Of French Authority's Pharma Sector Inquiry

Home
Perspectives & Events
Keep Watch Of French Authority's Pharma Sector Inquiry

Authors

Nathalie Jalabert-Doury

In a bylined article, Antitrust & Competition partners Nathalie Jalabert Doury (Paris), Kiran Desai, Robert Klotz, Jens Peter Schmidt (all Brussels) and Gillian Sproul (London) discuss the French Competition Authority's launch of a sector inquiry in the pharmaceutical sector.

Downloads –

Download Document

Related Capabilities

Practices –

Antitrust & Competition

Latest Perspectives

July 28

2022

Electronic Discovery & Information Governance – Tip of the Month: Spoliation Sanctions for Electronic and Non-electronic Evidence
July 21

2022

US FTC Continues Focus on Gig Economy with NLRB Agreement
July 07

2022

Is it conceivable in 2022 that companies still do not enjoy effective judicial review of the way Commission inspections are implemented?

Laurence Idot Liber Amicorum (French language)

Law360

Related Capabilities

Latest Perspectives